
    
      The investigator perform a prospective randomized, single-blinded study to investigate the
      dose effect of ESWT in patients with carpal tunnel syndrome.

      The evaluation was performed pretreatment as well as on the 4th, 8th, 12th, 16th and 24 week
      after the treatment.
    
  